[go: up one dir, main page]

NO920160L - CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES - Google Patents

CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES

Info

Publication number
NO920160L
NO920160L NO92920160A NO920160A NO920160L NO 920160 L NO920160 L NO 920160L NO 92920160 A NO92920160 A NO 92920160A NO 920160 A NO920160 A NO 920160A NO 920160 L NO920160 L NO 920160L
Authority
NO
Norway
Prior art keywords
lymphokine
cytokine
hormonabers
cytochine
conjugate vaccines
Prior art date
Application number
NO92920160A
Other languages
Norwegian (no)
Other versions
NO920160D0 (en
Inventor
Subramonia Pillai
Ronald Eby
Original Assignee
Praxis Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1990/003983 external-priority patent/WO1991001146A1/en
Application filed by Praxis Biolog Inc filed Critical Praxis Biolog Inc
Publication of NO920160D0 publication Critical patent/NO920160D0/en
Publication of NO920160L publication Critical patent/NO920160L/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Immunogene konjugater omfattende et karbohydratholdig antigen eller annet antigen bundet til, eller genetisk sam- mensmeltet med, et cytokin, lymfokin, hormon eller en vekst- faktor med ir.munmodulerende aktivitet, hvor cytokinet, lymfo- kinet, hormonet eller vekstfaktoren kan modifisere immunoge- niteten av det karbohydratholdige antigen. Cytokinet eller lymfokinet kan være et interleukin eller et interferon. Det immunogene konjugat kan anvendes i vaksine- og kovaksinepre- parater.Immunogenic conjugates comprising a carbohydrate-containing antigen or other antigen bound to, or genetically fused with, a cytokine, lymphokine, hormone or growth factor with immunomodulatory activity, wherein the cytokine, lymphokine, hormone or growth factor can modify the immunogen. the level of the carbohydrate-containing antigen. The cytokine or lymphokine may be an interleukin or an interferon. The immunogenic conjugate can be used in vaccine and covaxine preparations.

NO92920160A 1989-07-14 1992-01-13 CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES NO920160L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38056689A 1989-07-14 1989-07-14
PCT/US1990/003983 WO1991001146A1 (en) 1989-07-14 1990-07-16 Cytokine and hormone carriers for conjugate vaccines

Publications (2)

Publication Number Publication Date
NO920160D0 NO920160D0 (en) 1992-01-13
NO920160L true NO920160L (en) 1992-03-05

Family

ID=26781566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920160A NO920160L (en) 1989-07-14 1992-01-13 CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES

Country Status (1)

Country Link
NO (1) NO920160L (en)

Also Published As

Publication number Publication date
NO920160D0 (en) 1992-01-13

Similar Documents

Publication Publication Date Title
DK0668781T3 (en) Lymphocyte therapy of cancer in combination with tumor antigens
MX9203439A (en) A MAMMALIAN CYTOKINE, IL-11
DE69333859D1 (en) SELF-ASSOCIATED RECOMBINANT HPV16 PAPILLOMAVIRUS CROP PROTEINS
AU2953895A (en) Multi-stage cascade boosting vaccine
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
ES2002490A6 (en) Vaccines and immunoassays for acquired immune deficiency syndrome
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
DE60040740D1 (en) USE OF INTERLEUKIN-1 MUTEIN AS VACCINE ADJUVAN
DK0402070T3 (en) Crystalline r-h-GM-CSF and process for its preparation
FI102282B1 (en) Method for preparing O-glycosylated IGF-1
NO920160L (en) CYTOCHINE AND HORMONABERS FOR CONJUGATE VACCINES
BE839306A (en) ACTIVE IMMUNIZATION AGAINST VIRAL HEPATITIS VACCINE AND PREPARATION METHOD
DK0563254T3 (en) Use of IL-4 to enhance immune response to immunogens in vaccines
DE69637435D1 (en) SAPONIN COMPOSITIONS AND ITS USE
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
GR1001220B (en) Cytokine and hormone carriers for conjugate vaccines
ES8107300A1 (en) Herpes virus vaccine and its preparation.
JPWO2019213555A5 (en)
DK0503252T3 (en) Recombinant proteins with Hepatitis B virus e antigen (HBeAg) immunoreactivity, method for their preparation and their use in immunoassays and vaccines
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
DK477180A (en) VACCINE AND PROCEDURE FOR PREPARING IT
FR2331354A2 (en) ACTIVE IMMUNIZATION AGAINST VIRAL HEPATITIS VACCINE AND PREPARATION METHOD
AU8762591A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
FR2698271B1 (en) Bovine leukemia virus vaccine, new immunogenic peptide and vaccination kit.